Index number 50 /Up-to-Date

AUTOPLAK commercially available in Italy

From left to right the Managing Director of Biomedical Service Eddo Vanin and the Director of Healthcare Technology at SENER Íñigo Gurrea after signing the agreement.

From left to right the Managing Director of Biomedical Service Eddo Vanin and the Director of Healthcare Technology at SENER Íñigo Gurrea after signing the agreement.

NTE Healthcare, the high healthcare technology brand of the SENER group, has signed an exclusive distribution contract with Biomedical Service, by which the Italian company will market in Italy the AUTOPLAK device, designed and manufactured by NTE Healthcare.

Biomedical Service has extensive experience in the microbiology sector and has been distributing products for highly reputable brands in the Healthcare industry since 1982.

At the same time, AUTOPLAK has already been installed at Treviso Hospital in this same city, in Italy. There it is being tested by Dr. Roberto Rigoli, Head of the Microbiology Department, with a view to incorporating it into the routine operations of the laboratory by the end of 2015.

AUTOPLAK has already been installed at Treviso Hospital where it is being tested by Dr. Roberto Rigoli, Head of the Microbiology Department.

Italy is now the fourth country to install the AUTOPLAK device in its hospitals, following Spain (where it is already in the laboratories of Vall d’Hebron, Arnau de Vilanova, Joan XXIII and Vellvitge hospitals and in the Doctor Robert Primary Healthcare Center), Mexico (Central Military Hospital of the Mexican Defense Department) and Sweden, in the laboratory of Uppsala University Hospital.

This is another step in the international expansion of the AUTOPLAK sales network, following the reshape of the collaboration with Deltalab.

Copyright SENER 2017